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Abstract
Introduction: Electronic cigarette (e-cigarette) use rose substantially within the UK in recent
years but currently, Stop Smoking Services in England do not prescribe them due to a lack of
regulation. Previous research has examined e-cigarette use and attitudes within English Stop
Smoking Services using samples of practitioners and managers; the current study recruited a
sample of service users. Methods: Participants (N¼ 319) aged 18–60 years old were recruited
from Roy Castle FagEnds, Liverpool, England (Stop Smoking Service). A cross-sectional ques-
tionnaire was completed, which recorded demographic variables, e-cigarette use alongside risk
perception, and lastly, smoking behaviour i.e. smoking duration, cigarettes per day, and
nicotine dependence. Results: Most participants were female (57.1%), current smokers (53.0%),
and current or former e-cigarette users (51.7%). Participants who perceived e-cigarettes as less
harmful than smoked tobacco were more likely to have smoked fewer cigarettes per day
(p¼ 0.008). Furthermore, those who felt uncertain whether e-cigarettes were safer than smoked
tobacco, were less likely to have tried them (p50.001). Conclusion: This study suggests that
e-cigarette use is becoming common among users of Stop Smoking Services (despite
e-cigarettes being unavailable from such services) and that e-cigarette risk perception is related
to e-cigarette status. The results highlight the importance of providing smokers intending to
quit smoking with current and accurate e-cigarette information. Findings may inform future
Stop Smoking Services provision and the results demonstrate that further research is warranted.
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Introduction
Electronic cigarettes (e-cigarettes) are battery-powered
devices that deliver nicotine to the user and tend to be
marketed as a less harmful alternative to smoked tobacco
(Bauld, Angus, & De Andrade, 2014). The popularity of
e-cigarettes in Great Britain has grown substantially within
recent years (Action on Smoking and Health, 2014; Dockrell,
Morrison, Bauld, & McNeill, 2013) but despite this, there is
ongoing debate within the research community regarding the
safety and efficacy of e-cigarettes as smoking cessation tools
(Ashton, 2014; Watson & Forshaw, 2014).
E-cigarettes have been linked to reduced cigarette con-
sumption and increased smoking cessation rates, although the
majority of results have been based upon survey data and
prospective trials, rather than randomised controlled trials
(Bullen et al., 2013; Caponnetto, Auditore, Russo, Cappello,
& Polosa, 2013; Caponnetto, et al., 2013; Caponnetto, Polosa,
Russo, Leotta, & Campagna, 2011; Etter & Bullen, 2011,
2014; Pokhrel, Fagan, Little, Kawamoto, & Herzog, 2013;
Polosa et al., 2011, 2014; Siegel, Tanwar, & Wood, 2011).
Toxic chemicals have been identified in e-cigarette vapour
(Hadwiger et al., 2010; Kim & Shin, 2013; Ohta, Uchiyama,
Inaba, Nakagome, & Kunugita, 2011), but one review
concluded that e-cigarette vapour is substantially lower in
toxic content, cytotoxicity, associated adverse effects and
passive toxicity exposure, when compared to tobacco smoke
(Harrell, Simmons, Correa, Padhya, & Brandon, 2014).
Further to this, Nutt et al. (2014) developed a multi-criteria
decision analysis model, which ordered nicotine containing
products by harm to users. Their calculations suggested that
harm associated with e-cigarette use was extensively lower
than smoked tobacco and similar to other nicotine replace-
ment therapies. Current results are promising but further
research is warranted to establish any potential long-term
health implications associated with e-cigarette use (Ashton,
2014; Grana, Benowitz, & Glantz, 2014). The National
Institute for Health and Care Excellence (NICE) (2013)
provides guidance for practitioners, managers and commis-
sioners working in public health, in which it recommends the
use of licensed nicotine replacement products (e.g. nicotine
patches) for smoking cessation and relapse prevention.
The recently approved European Tobacco Product Directive
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(TPD) subjects e-cigarettes that make medicinal claims
regarding smoking cessation or harm reduction and/or
products containing above 20 mg/ml nicotine to a medicinal
regulatory regime (European Commission, 2014). Products
classified as medicinal will be licensed by the Medicines and
Healthcare products Regulatory Agency (MHRA) by 2016
(MHRA, 2013).
Considering smoking cessation support, there has been a
gradual increase in the number of Stop Smoking Services
(SSS) offered globally across various countries and although
these services vary in regard to structure, all offer some form
of support for smokers who wish to stop smoking (Pine-Abata
et al., 2013). SSSs in the UK have possibly one of the most
comprehensive approaches. Such services implement evi-
dence-based behavioural and pharmaceutical interventions to
help smokers to quit smoking and they have proven to be a
highly effective approach to reducing smoking prevalence
(Ferguson, Bauld, Chesterman, & Judge, 2005; Judge, Bauld,
Chesterman, & Ferguson, 2005). Currently, e-cigarettes are
not provided by SSSs as they are unlicensed, but if some
e-cigarettes gain a medicinal licence in the future, guidance
and supply of e-cigarettes within SSSs may change (National
Centre for Smoking Cessation and Training [NCSCT],
2014b). The NCSCT (2014a) identified that SSSs were
struggling to decide what role they should play in regard to
e-cigarettes and how practitioners should respond to queries
regarding them. The guidance recommended that practitioners
be open to clients interested in trying e-cigarettes.
To our knowledge, only two published studies have
examined e-cigarette use within SSSs but both rely upon the
reports of SSSs practitioners or managers. The earliest study
highlighted an increase in e-cigarette use amongst clients,
with 90% of SSS practitioners reporting e-cigarettes being
used (Beard, Brose, Brown, West, & McEwen, 2014). The
most recent study compared the results of a SSSs practitioner
survey undertaken in 2011 with a repeated survey completed
in 2013 (Hiscock et al., 2014). The findings suggested that
e-cigarette use in SSSs has increased and that practitioners
often felt uncertain about providing advice on e-cigarette use
and safety. The annual Statistics on NHS Stop Smoking
Services report will be available later in 2015 and will include
data on the use of unlicensed nicotine containing products in
services for the first time. However, preliminary results
suggest that only 2% of service users have reported using
unlicensed nicotine containing products for their quit attempt
(Health and Social Care Information Centre, 2014b).
A number of studies have also explored e-cigarette risk
perception among current and former smokers from the
general populations in Britain. A smokers’ survey conducted
across Great Britain in 2010 suggested that 71% of smokers
perceived e-cigarettes to be safer than smoked tobacco
(Dockrell et al., 2013). More recently, Brown et al. (2014)
found that 67% of a sample combining current and former
smokers, perceived e-cigarettes to be less harmful than
smoked tobacco, whilst 24% felt unsure whether e-cigarettes
were safer. Tan and Bigman (2014) suggested that behaviour
change theories, such as The Theory of Planned Behaviour
(Norman, Conner, & Bell, 1999) and The Transtheoretical
Model of Change (DiClemente et al., 1991) might provide
explanations regarding the role of e-cigarette risk perception
in influencing psychosocial variables linked with smoking
cessation (e.g. subjective norms in relation to perceived
e-cigarette harm, or self-efficacy towards using an e-cigarette
for cessation) which subsequently impacts upon smoking
cessation. This highlights the importance of exploring the role
of e-cigarette risk perception for individuals making smoking
cessation treatment decisions.
Recording e-cigarette use and behaviours will enable
planning for future provision and delivery of SSSs, whilst
establishing e-cigarette risk perception among clients, will
enable us to determine their knowledge regarding e-cigarettes.
Ensuring the e-cigarette information clients receive is
unbiased, up-to-date and accurate, will enhance understand-
ing and enabling clients to make educated smoking cessation
treatment choices. The current survey study recruited clients
engaging in SSSs and examined their e-cigarette use and risk
perception.
Methods
Participants and procedures
Participants (N¼ 319) between the ages of 18–60 years old
consented to take part in the study via community support
groups, provided by the SSS, Roy Castle FagEnds (Liverpool,
England). Host locations across Liverpool varied, some of
which included: GP surgeries, hospital clinics, children’s
centres, and libraries. Liverpool remains the most deprived
local authority in England (Liverpool City Council, 2011);
furthermore, the smoking rate among adults in Liverpool is
24.5% compared to the national average of 19.5% (Public
Health England, 2014). Between November 2013 and June
2014 participants completed a questionnaire with a researcher
which examined demographic characteristics, smoking behav-
iour, and e-cigarette use and risk perception. The sample
consisted of both current (53.0%) and recent former smokers
(47.0%); Roy Castle FagEnds provided a rolling stop-smoking
support programme, and therefore participants were at
varying stages throughout their smoking cessation experience.
Liverpool Central, National Research Ethics Service
Committee provided full ethical approval for the study;
strict confidentiality guidelines were adhered to, participants
were made aware that they could withdraw from the study at
any time and data were anonymised. Participants were
informed that results may be published in a scientific journal,
but only anonymised data would be referred.
Measures
The questionnaire took approximately 5–10 minutes to
complete. Questions were divided into three sections:
(1) demographic characteristics, (2) smoking behaviour, and
(3) electronic cigarettes.
Demographic characteristics
Demographic characteristics included: age, sex, education,
and ethnicity. Education was dichotomised into: (1) basic or
no qualifications (i.e. General Certificate of Secondary
Education [GCSE] or below), or (2) higher qualifications
(i.e. achieving qualifications beyond GCSE level).
Participants were offered 18 response options for the ethnicity
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variable, including: White British (n¼ 282), White Irish
(n¼ 7), White Other (n¼ 4), Black African (n¼ 1), Black
Other (n¼ 9), Asian Pakistani (n¼ 1), Ethnic Other (n¼ 1),
Mixed Asian (n¼ 2), Mixed Caribbean (n¼ 2), Mixed Other
(n¼ 2), and Other (n¼ 6). As the majority of participants
were classified as White British, White Irish or White Other
(92.4%) and the remaining participants (n¼ 24) were divided
between 8 further ethnicities, for statistical purposes, it was
necessary to recode ethnicity values into two categories:
(1) White (White British, White Irish, and White Other), and
(2) Other, mixed, and unknown (Black African, Black Other,
Asian Pakistani, Ethnic Other, Mixed Asian, Mixed
Caribbean, Mixed Other, Other).
Smoking behaviour
A number of variables were examined regarding client
smoking behaviour. Smoking status was measured using
7-day period prevalence: ‘‘Have you smoked one or more
cigarettes within the past week?’’ Response options included:
‘‘Yes’’ or ‘‘No’’; participants who responded ‘‘Yes’’ were
considered current smokers, whilst participants who answered
‘‘No’’, were considered recent former smokers. Cigarettes per
day (i.e. smoked tobacco) were measured: ‘‘How many
cigarettes per day do you smoke?’’ Smoking duration was
calculated by asking: ‘‘How old were you when you started
smoking?’’ and this figure was deducted from age to calculate
smoking duration (having considered any gaps in smoking
duration with the participant). Participants recorded the
number of cigarettes per day they smoked. Nicotine depend-
ence was measured using the Fagerstrom Test for Nicotine
Dependence (FTND) (Heatherton, Kozlowski, Frecker, &
Fagerstrom, 1991). FTND scores were calculated based on six
items and scores ranged from 0 to 10; low to high
dependency. FTND scores were recoded into nicotine
dependence levels (Fagerstrom, Heatherton, & Kozlowski,
1990): ‘‘Very low’’ (0-2), ‘‘Low’’ (3–4), ‘‘Medium’’ (5),
‘‘High’’ (6–7), and ‘‘Very High’’ (8–10). For individuals who
identified themselves as recent former smokers, cigarettes per
day and the FTND were adapted to reflect habits prior to
quitting.
Electronic cigarettes
The measures used to assess e-cigarette use and attitudes were
divided into two sub-sections. The first sub-section included
two questions which all participants completed. Firstly,
e-cigarette ever used was measured with the question:
‘‘Have you ever used an electronic cigarette?’’ Participants
who responded ‘‘Yes’’ were considered ever users, whilst
participants who responded ‘‘No’’ were considered never
users. Secondly, the measure for e-cigarette perceived harm
from a recent study (Sutfin, McCoy, Morrell, Hoeppner, &
Wolfson, 2013) was asked: ‘‘Compared with regular cigar-
ettes, how harmful do you think electronic cigarettes are?’’
Participants responded: ‘‘Less harmful than cigarettes’’, ‘‘As
harmful as cigarettes’’, ‘‘More harmful than cigarettes’’, or
‘‘Don’t know’’.
Participants who had identified themselves as e-cigarette
ever users were required to complete additional questions on
e-cigarette use. Within this section, ever users were asked
further questions regarding patterns of use. The first two
questions were adapted from a recent survey (Goniewicz,
Lingas, & Hajek, 2013). Firstly, e-cigarette status was
established with the question: ‘‘When did you last use an
electronic cigarette?’’ Participants responded: ‘‘Within the
past month’’, ‘‘Within the past 1–6 months’’, or ‘‘More than
6 months ago’’. Current users were defined as having used an
e-cigarette within the past month, whilst others were
categorised as former users. Secondly, frequency of
e-cigarette use per day was explored: ‘‘How many times a
day do/did you use an e-cigarette?’’ Response options
included: ‘‘5 times or less’’, ‘‘6–15 times a day’’, ‘‘16–25
times per day’’, or ‘‘Over 25 times per day’’. To our
knowledge, intended duration of e-cigarette use had not
previously been measured, therefore, the following question
was posed: ‘‘Do/did you use an e-cigarette as. . .’’ Potential
responses included: ‘‘A long-term or permanent replacement
for regular cigarettes’’, ‘‘A short-term stop-smoking aid’’, or
‘‘Not sure’’. Lastly, the study also aimed to explore whether
participants had used an e-cigarette in a location where they
would not normally have smoked tobacco. However, at the
time the questionnaire was developed there was no previously
validated measure available to our knowledge, therefore the
following question was included: ‘‘Do/did you find yourself
using the e-cigarette anywhere that you wouldn’t normally
smoke a regular cigarette?’’ Participants could respond:
‘‘Yes’’ or ‘‘No’’, with an open text box enabling them to state
a location if applicable.
Analysis
Differences between electronic cigarette use and risk percep-
tion in socio-demographic and smoking characteristics were
examined using 2 test or Fisher’s exact test as appropriate
for categorical variables. For continuous variables, Kruskal–
Wallis tests were undertaken to identify significant differ-
ences between variable levels. All analyses were performed
using STATA version 13.1 (StataCorp, College Station, TX)
and IBM-SPSS statistical software version 21.0 (New York,
NY), Q1and a p value 0.05 wasconsidered statistically
significant.
Results
Three-hundred and nineteen participants completed a ques-
tionnaire. Table 1 depicts the distribution of the key
participant characteristics across the study population. The
median age was 45.0 years old (interquartile range
[IQR]¼ 36–52) and the majority of participants were
female (57.1%) and Caucasian (94.2%). The median number
of cigarettes per day and the median smoking duration were
20.0 cigarettes (IQR¼ 15–30) and 29.0 years (IQR¼ 20–38),
respectively. Only over half of the participants reported
having ever used an e-cigarette (n¼ 165, 51.7%). However, no
significant relationships were identified between e-cigarette
ever use and all participant characteristics recorded in Table 1
(i.e. age, sex, ethnicity, education, smoking status, cigarettes
per day, smoking duration, or nicotine dependence).
Of e-cigarette ever users, 45.5% were current users
(Table 2). The most common frequency of use was 5 times
per day or less (41.1%). Current users were more likely to
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report lower frequencies of use per day compared to former
users (p¼ 0.015). The majority of e-cigarette ever users had
intended on using e-cigarettes for the short-term (73.9%).
Many e-cigarette users reported having used their e-cigarette
in a location they would not normally have smoked tobacco
(Table 2). Reported locations varied but included: in their
own home (28.2%), in pubs/bars (21.2%), on public transport
(12.9%), at work (12.9%), in shops (7.1%), eating out (4.7%),
in the car (4.7%), everywhere (4.7%), in a hotel (2.4%), and in
hospital (1.2%).
Overall, nearly half of the participants viewed e-cigarettes
as less harmful than smoked tobacco (48.2%, n¼ 149) and a
large number of participants felt uncertain whether e-cigar-
ettes were safer than smoked tobacco (38.8%, n¼ 120).
There were no significant differences between e-cigarette risk
perception and age, sex, ethnicity, education, smoking status,
smoking duration, and nicotine dependence (Table 3). Table 3
displays the significant differences between e-cigarette risk
perception and e-cigarette status (p50.001) and cigarettes
smoked per day (p¼ 0.008). Current users were more likely to
view e-cigarettes as less harmful than former or never users,
whilst never users were most uncertain if e-cigarettes were
safer than smoked tobacco. Furthermore, participants who
viewed e-cigarettes as less harmful than smoked tobacco were
more likely to smoke fewer cigarettes per day, whilst those
who reported feeling uncertain whether e-cigarettes were
safer tended to smoke a greater number of cigarettes per day.
Discussion
To our knowledge, this is the first study that has interviewed
UK SSS clients regarding e-cigarette use and perceptions of
risk. E-cigarette use was substantially higher (51.7%) than
previously estimated; a recent survey (conducted in 2013)
detailed only 12.2% of practitioners thought that a significant
proportion (50–75%) of their clients were using or had used
an e-cigarette (Hiscock et al., 2014); it is possible that
practitioners underestimated e-cigarette use. The present
study also found that current use of e-cigarettes in SSSs is
substantially higher than the levels suggested by recent
preliminary national data (Health and Social Care Information
Centre, 2014b). Differences could be attributed to SSS clients
feeling uncomfortable disclosing e-cigarette use with SSSs
practitioners (perhaps due to them being unlicensed), vari-
ations in study recruitment dates or potentially, there are
Table 1. Differences in participant characteristics by e-cigarette ever use.
Participant characteristics
E-cigarette ever
users n (%)
E-cigarette never
users n (%) Total n (%)
Age summary statistic
Median (IQR) 44.0 (36–53) 47.0 (37–53) 45.0 (36–52)
18–30 years 26 (15.8) 19 (12.3) 45 (14.1)
31–40 years 35 (21.2) 31 (20.1) 66 (20.7)
41–50 years 53 (32.1) 50 (32.5) 103 (32.3)
51–60 years 51 (30.9) 54 (35.1) 105 (32.9)
Sex
Female 101 (61.2) 81 (52.6) 182 (57.1)
Ethnicitya
White (vs. Other, mixed, and unknown) 153 (95.6) 140 (90.9) 293 (94.2)
Educationa
Basic or no qualifications (vs. higher qualifications) 85 (56.7) 68 (44.2) 153 (52.8)
Smoking status
Current 94 (57.0) 72 (46.8) 150 (47.0)
Cigarettes per day
Median (IQR) 20.0 (15–30) 20.0 (15–30) 20.0 (15–30)
Smoking duration
Median (IQR) 28.5 (20–38) 29.0 (21–37) 29.0 (20–38)
Nicotine dependencea
Very low 15 (9.2) 19 (12.5) 34 (10.8)
Low 19 (11.7) 24 (15.8) 43 (13.7)
Medium 32 (19.6) 28 (18.4) 60 (19.0)
High 59 (36.2) 44 (28.9) 103 (32.7)
Very high 38 (23.3) 37 (24.3) 75 (23.8)
aTotal participants for variable may not equal 319 due to some missing data.
Table 2. Patterns of use among e-cigarette ever users.
E-cigarette behaviour n %
Last used e-cigarettea
Within the past month (current users) 71 45.5
Within the past 1–6 months (formers users) 44 28.2
More than 6 months ago (former users) 41 26.3
Frequency of use per daya
5 times 62 41.1
6–15 times 40 26.5
16–25 times 20 13.2
25 times 29 19.2
Intended duration of e-cigarette usea
Long-term 31 20.3
Short-term 113 73.9
Unsure 9 5.9
E-cigarette use in a location they wouldn’t
smoke tobaccoa
Yes 70 46.4
No 81 53.6
aTotal participants for variable may not equal 165, i.e. total e-cigarette
ever users. This is due to some missing data.
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higher levels of e-cigarette use within this particular sample
or within Liverpool.
Patterns of use were also measured in the present study.
Users mostly viewed e-cigarettes as a short-term smoking
cessation tool (73.9%), whereby they presumably intended on
weaning themselves off the product within a limited time.
Short-term nicotine replacement therapy is established as an
effective and safe approach to fostering smoking cessation
(Shields, 2011). Contrary to this, a proportion of participants
did view e-cigarettes as a product which they intended to
use long-term (20.3%). NICE (2013) also advise nicotine-
containing products ‘‘for the long-term, if necessary, to
prevent relapse’’ (p. 16), but they have identified a number of
gaps in research in relation to the safety of long-term nicotine
exposure. In future, if some e-cigarettes are regulated as
medicinal products and used long-term by many, this could
challenge the shorter-term approach to smoking cessation
treatment that is often adopted by SSSs.
Common use of e-cigarettes in public locations (Table 2)
might suggest that many e-cigarette users do not perceive
e-cigarette vapours as harmful to others. Ballbe` et al. (2014)
conducted an observational study in which they found that
salivary cotinine (a metabolite of nicotine) was more than
twice as high for non-smokers living in e-cigarette users’
homes, compared to those living in control homes. However,
cotinine levels amongst non-smokers living in smoking
households were over five times higher compared to the
control homes. There is currently a deficit of research
regarding the impact of passive e-cigarette vapour exposure,
so the health implications, if any, are uncertain. As discussed
earlier, a number of studies have associated e-cigarettes with
smoking cessation success but it would also be of interest to
consider future smoking behaviour amongst e-cigarette users
who relapse, especially among those who used e-cigarettes
in locations which they would not normally have smoked
tobacco in, as it is currently unclear which habits smokers
return to.
Reported cigarettes per day were fewer among those who
viewed e-cigarettes as less harmful than smoked tobacco and
higher among participants who felt that they were unsure
whether e-cigarettes were safer; further research is warranted
to explore this relationship in greater detail. The results also
suggest that individuals who feel uncertain regarding the
safety of e-cigarettes may avoid trying them and those who
view them as safer than smoked tobacco may be more likely
to use them. Although causality cannot be inferred, the
findings do imply that attitudes towards risk are related to
use and this association fits well with previously discussed
behaviour change theories, e.g. The Theory of Planned
Behaviour (Norman et al., 1999); one possibility for future
research might be to explore the application and use of such
models in this context, using a longitudinal design.
Additionally, the results suggest that SSS users (within this
service at least) are substantially more likely to feel uncertain
whether e-cigarettes are less harmful than smoked tobacco,
compared with a more general sample of British current and
recent former smokers (Brown et al., 2014).
The reported inflated perception of e-cigarette risk was
unanticipated in light of the growing body of research that
suggests e-cigarettes are substantially safer than smoked
tobacco (e.g. Hajek, Etter, Benowitz, Eissenberg, &
McRobbie, 2014; Nutt et al., 2014). This has relevance in
relation to cognitive dissonance, which occurs when a person
holds at least two opposing but related cognitions, which
Table 3. The relationship between perceived e-cigarette harm and participant characteristics.
Participant characteristics
Less harmful
than cigarettes
n (%)
As harmful
as cigarettes
n (%)
More harmful
than cigarettes
n (%)
Not sure
n (%) p Value
Age summary statistic 0.687
Median (IQR) 46.5 (36–52) 42.0 (34–51) 45.0 (36–55) 45.0 (37–53)
Sex 0.556
Female 87 (56.5%) 23 (67.6%) 3 (42.9%) 68 (56.2%)
Ethnicitya 0.073
White (vs. Other, mixed, and unknown) 146 (96.1%) 34 (100.0%) 5 (83.3%) 106 (91.4%)
Educationa 0.116
Basic or no qualifications (vs. higher qualifications) 73 (52.5%) 12 (35.3%) 3 (42.9%) 63 (58.3%)
Smoking status 0.527
Current (vs. recent former smoker) 73 (47.4%) 20 (58.8%) 3 (42.9%) 54 (44.6%)
Cigarettes per daya 0.008*
Median (IQR) 20.0 (15–20) 20.0 (15–30) 20.0 (15–25) 20.0 (20–30)
Smoking duration 0.331
Median (IQR) 30.0 (21–38) 25.0 (18–34) 27.0 (20–43) 29.0 (20–37)
Nicotine dependencea 0.139
Very low 21 (13.8%) 4 (11.8%) 2 (28.6%) 7 (5.8%)
Low 21 (13.8%) 10 (29.4%) 1 (14.3%) 11 (9.2%)
Medium 25 (16.4%) 4 (11.8%) 1 (14.3%) 30 (25.0%)
High 50 (32.9%) 11 (32.4%) 1 (14.3%) 41 (34.2%)
Very high 35 (23.0%) 5 (14.7%) 2 (28.6%) 31 (25.8%)
E-cigarette statusa 50.001*
Current 50 (70.4%) 3 (4.2%) 1 (1.4%) 17 (23.9%)
Former 39 (45.9%) 9 (10.6%) 3 (3.5%) 34 (40.0%)
Never 60 (39.2%) 22 (14.4%) 2 (1.3%) 69 (45.1%)
aTotal participants for variable may not equal 309, i.e. total respondents to risk perception measure. This is due to some missing data.
*p50.01
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can result in mental conflict (Festinger, 1957, 1962).
Consequentially, individuals may deny or distort information
perceived as threatening in an attempt to reduce dissonance
and mental conflict (Kleinjan, van den Eijnden, Dijkstra,
Brug, & Engels, 2006). This concept is relevant to the current
study results, as some smokers may have distorted e-cigarette
information, resulting in inflated e-cigarette risk perception,
thus enabling continued smoking through reduced mental
conflict. One should also consider the accuracy and balance
of information current and recent former smokers are
receiving. For example, Rooke and Amos (2013) suggested
that ‘‘risk and uncertainty’’ was one of a number of recurrent
themes adopted by UK newspaper coverage regarding
e-cigarettes, but it is unclear how these stories are embodied
by smokers. This warrants further investigation to ascertain
understandings of safety and efficacy surrounding e-cigarettes
amongst both SSSs clients and current and former smokers
overall.
There are a few limitations to the study. Firstly, the results
are based upon cross-sectional data and therefore, causality
cannot be inferred in regard to the relationships between e-
cigarette use and risk perception. Secondly, as the results rely
on self-reports, there may have been some recall bias. For
example, former e-cigarette users retrospectively reported
increased frequent use per day compared to current users.
This may have been due to former users accurately recalling
greater use and the subsequent discontinuation of the product
could have been born out of concerns around excessive use.
Conversely, the differences could also be due to under-
reporting amongst current users; perhaps some felt uncom-
fortable reporting frequent use of an unlicensed product. A
longitudinal design may help to establish why differences in
reported frequency of e-cigarette use occurred between
current and former e-cigarette users.
The design of some of the measures should also be
considered when interpreting the results. Seven day period
prevalence was used to classify current and recent former
smokers; for occasional smokers, this measure may be less
reliable. Current e-cigarette use was defined as having used
the product within the previous month. However, individuals
who have experimented with e-cigarettes on one occasion
several weeks prior would therefore be classified as a current
user; future research should consider a more elaborate
measure of status. Further research could also incorporate a
more comprehensive list of response options in relation to the
measures pertaining to long- or short-term e-cigarette use and
locations of use; further options will enable the researcher to
explore such behaviours more in-depth.
In comparison to the age distribution of SSS clients across
England, SSS clients in Liverpool are of a slightly older age
range (Health and Social Care Information Centre, 2014a),
which was reflected in our sample. The older age range may
additionally be reflected in the results regarding smoking
duration and cigarettes per day; cigarettes per day were higher
than the national average (Office for National Statistics,
2013). Liverpool is also the most deprived local authority in
England (Liverpool City Council, 2011) and e-cigarette use
has been associated with higher socio-economic status in
Britain (Brown et al., 2014). Therefore, the results may not be
representative of e-cigarette use across all SSSs in England, or
indeed other countries. However, the study provides an
in-depth snapshot of e-cigarette use within one support
service and also, details the perceptions of e-cigarette harm
among clients. It is essential that future research examines
e-cigarette use among varying populations, including clients
engaging in health services. Additionally, perceptions of
e-cigarette harm among smokers should continue to be
monitored to ensure that smokers are receiving and under-
standing balanced, accurate e-cigarette information.
Conclusion
The study findings, considered alongside the documented
increases in e-cigarette use in Great Britain (ASH, 2014;
Dockrell et al., 2013), suggest that e-cigarette use is prevalent
within UK SSSs and that there is a strong relationship
between e-cigarette status and risk perception. At a pivotal
time in the development of e-cigarettes both nationally and
internationally, these findings emphasise the importance of
consistent e-cigarette measurement within SSSs to enable
improvements in future planning and provision of services.
Furthermore, the reported uncertainties around e-cigarette
use highlight the important role practitioners may hold in
providing clients with accurate, up-to-date, and unbiased
e-cigarette information, which should result in the enablement
of clients to make informed, educated decisions regarding
smoking cessation treatments.
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